Thus, these correlations of IDO1 and TDO2 in glioblastoma have led to a hypothesis that IDO1 or TDO2 enzyme inhibition could offer a novel therapeutic approach in the treatment of the disease [23–25]. This evidence concerns the gene TDO2 and glioblastoma.